School of Medicine
Showing 251-300 of 502 Results
-
Blake Thomson
MD Student with Scholarly Concentration in Health Services & Policy Research, expected graduation Spring 2027
BioBlake Thomson is a health disparities researcher and medical student at Stanford. An epidemiologist by training, he holds an MPhil in Epidemiology from the University of Cambridge and a DPhil (PhD) in Population Health from the University of Oxford. He has held several posts focused on health equity science, including most recently as Principal Scientist in Cancer Disparities Research at the American Cancer Society.
Blake has authored or co-authored more than 30 articles in medical and public health journals, including The Lancet and JAMA. His first-author publications have appeared in such journals as The Lancet Global Health, JAMA Internal Medicine, JAMA Oncology, JAMA Neurology, Chest, and Circulation, among others. This work has received media attention from such outlets as The Washington Post, Nature, and National Geographic. His clinical and academic interests are focused on the prevention and control of common and debilitating diseases, particularly among those historically underrepresented in medical research. -
Alan Eih Chih Thong
Clinical Associate Professor, Urology
BioDr. Thong is a surgeon specializing in urologic oncology. He has expertise in all aspects of prostate, kidney, bladder, and testicular cancer care, including endoscopic, robotic, and open surgery, and has a special interest in complex cases including: salvage surgery following radiation or chemotherapy, resection of locally advanced tumors, minimal access robotic surgery, and MRI-US fusion targeted biopsies. Dr. Thong is the first surgeon in northern California to utilize single port robotic assisted laparoscopic technology for both pelvic and retroperitoneal surgeries. He has won numerous awards including the NIH Ruth L. Kirschstein National Research Service Award, and has authored and co-authored publications on the treatment of urologic cancers.
-
Zachary David Threlkeld
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Threlkeld cares for critically ill patients with acute neurologic illness, including traumatic brain injury, stroke, intracerebral hemorrhage, and epilepsy. He completed his residency training in neurology at the University of California, San Francisco, and joined the Stanford Neurocritical Care program after completing fellowship training in neurocritical care at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. He has a particular clinical and research interest in traumatic brain injury. His research uses advanced imaging modalities like functional magnetic resonance imaging (fMRI) to better understand disorders of consciousness.
-
Lu Tian
Professor of Biomedical Data Science and, by courtesy, of Statistics
Current Research and Scholarly InterestsMy research interest includes
(1) Survival Analysis and Semiparametric Modeling;
(2) Resampling Method ;
(3) Meta Analysis ;
(4) High Dimensional Data Analysis;
(5) Precision Medicine for Disease Diagnosis, Prognosis and Treatment. -
Robert Tibshirani
Professor of Biomedical Data Science and of Statistics
Current Research and Scholarly InterestsMy research is in applied statistics and biostatistics. I specialize in computer-intensive methods for regression and classification, bootstrap, cross-validation and statistical inference, and signal and image analysis for medical diagnosis.
-
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
BioDr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now FDA approved. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of 6 FDA-approved drugs. He previously served as the Founder and Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. In 2022, Horizon was sold to Amgen for $28B. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. He founded and taught the Masters in Translational Research and Applied Medicine, one of the only translational medicine programs at Stanford. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health, as co-Director of the Drug Device Development Program he started in 2017 and as a Senior Advisor for the Center for Pediatric and Perinatal Education (CAPE). He focuses most of his efforts currently on improving scientific data integrity in published literature. -
Seda Tierney
Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsAssessment of vascular health in children by non-invasive modalities
Exercise interventions in children with congenital and acquired heart disease
Use of telehealth to deliver interventions to children with congenital and acquired heart disease
Parentally-acquired echocardiograms
Quality Improvement in Pediatric Echocardiography
Echocardiography and outcomes in congenital heart disease -
Hemali Vijay Panchal
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement, Patient Safety, Medical Education
-
Molly Timmerman
Clinical Assistant Professor (Affiliated), Orthopaedic Surgery
BioDr. Molly Timmerman is board-certified in Physical Medicine and Rehabilitation. She is Affiliated Clinical Assistant Professor of Physical Medicine and Rehabilitation/Orthopedic Surgery. She practices at Veterans Health Administration in Palo Alto, where she is Medical Director of Regional Amputation Center and the Polytrauma Network Site. She specializes in traumatic brain injury, post-traumatic headache management, and amputation medicine.
-
Alice Ting
Professor of Genetics, of Biology and, by courtesy, of Chemistry
Current Research and Scholarly InterestsWe develop chemogenetic and optogenetic technologies for probing and manipulating protein networks, cellular RNA, and the function of mitochondria and the mammalian brain. Our technologies draw from protein engineering, directed evolution, chemical biology, organic synthesis, high-resolution microscopy, genetics, and computational design.
-
Daniel SW Ting
Adjunct Clinical Associate Professor, Ophthalmology
BioAssoc Prof Daniel Ting is a senior consultant vitreo-retinal surgeon working in the Singapore National Eye Center (SNEC), an Associate Professor with Duke-NUS Medical School and an Adjunct Clinical Associate Professor and an Innovation Mentor at Stanford University. He is also the Director of Singapore Health Service (SingHealth) AI Office, SNEC Chief Data and Digital Officer, and the Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI). In 2017, Dr Ting was US-ASEAN Fulbright Scholar visiting the Johns Hopkins University Fulbright Scholar to share his expertise in AI and big data in medicine. In addition to that, his research focus span across not only on the technical aspect on machine learning, deep learning, large language models, explainable AI, privacy preserving technologies, but also safe, responsible and ethical clinical AI applications. He is also involved in several international consensus reporting guidelines such as STARD-AI, QUADAS-AI and DECIDE-AI.
To date, Daniel has published >250 publications on peer reviewed, book chapters, educational articles and conference abstracts. Of those, 45 were published in high impact journals (IF >10) such as JAMA, NEJM, Lancet, Nature Medicine, Nature Biomedical Engineering, Lancet Digital Health, Progress in Retinal and Eye Research, Diabetes Care, Nature Digital Medicine, Ophthalmology and etc. As of Aug 2024 (Google Scholar), his current H index: 61, i-10 index: 172 with total citations of >20,000. Dr Ting has received a total of 100M research grants, in which 20 M as a principal investigator, and 80M as co-investigators on AI and digital innovation related projects in health.
Dr Ting serves in several leadership positions at the different AI and eye societies, including the American Academy of Ophthalmology AI and Retina Ophthalmology Technology Assessment committees, and he also chairs the AI and Digital Innovation Standing Committee for the Asia-Pacific Academy of Ophthalmology and Asia-Pacific Vitreo-Retinal Society. He also serves in numerous advisory and editorial boards in the top-tiered digital and medical journals, including Lancet Digital Health, Frontiers in Medicine, Frontiers in Digital Health and Asia-Pacific Journal of Ophthalmology; Section Editor in British Journal of Ophthalmology and Editorial Board Member in Ophthalmology, Ophthalmology Retina, Ophthalmology Science, British Journal of Ophthalmology, Asia-Pacific Journal of Ophthalmology and Retina.
For the accomplishment, Dr Ting was recognized by many top-tiered international AI and ophthalmology societies in winning many prestigious scientific awards, including Tatler Asia Gen T Award (2021), Singapore National Clinician Scientist Award (2021), Asia-Pacific Academy Ophthalmology (APAO) Nakajima Award (2021), Asia-Pacific Vitreo-Retinal Society (APVRS) Ian Constable Award (2021), MICCAI OMIA Prestigious Achievement Award (2020), ARVO Bert Glaser Award for Innovative Research in Retina (2020), USA Macula Society Evangelos Gragoudas Award (2019), APAO Young Ophthalmologist’s Award (2018) and APTOS Young Innovator Award (2017).
In 2022, 2023 and 2024, he is included in the World’s Top 100 Ophthalmology Power list by the Ophthalmologists; and the World’s Top 2% Scientists by the Stanford University world ranking. In 2021, 2022 and 2023, he was consistently ranked top 3 in the deep learning domain over the past decades (2010 – 2023) by the ExpertScape. In 2024, he won the Singapore National Academy of Medicine Young Scientist Award, and also ranked the Top 100 AI Thought Leaders Worldwide with Fei Fei Li, Yan LeCun, Jensen Huang and many others by H20.ai. -
Jamie L. Tingey, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Research and Scholarly InterestsDr. Tingey’s research broadly focuses on factors that promote positive outcomes in patients with complex and/or chronic conditions. She is committed to research that focuses on outcomes that are valued by patients and healthcare stakeholders.
Some of her research interests include self-management interventions in chronic conditions (e.g., multiple sclerosis, stroke, spinal cord injury, traumatic brain injury) and adapting evidence-based treatments to provide equitable care to individuals with chronic conditions and disabilities. She is also passionate about integrating psychology services into critical care settings to improve health outcomes among ICU survivors. -
Julie Tinklenberg
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center
BioDr. Julie Tinklenberg specializes in the treatment of mental illness in the university setting. She has worked in college mental health for over 15 years. Dr.Tinklenberg has a special interest in anxiety disorders, parenting issues, mood disorders and interpersonal/relationship problems.
-
Jyothi Tirumalasetty, MD, FAAAAI, FACAAI
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsReducing healthcare-related carbon emissions with a focus on inhalers.
Health disparities in food allergy.
Climate change and asthma. -
Christina (Christy) Tise, MD, PhD
Assistant Professor of Pediatrics (Genetics)
BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.
Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.
Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!
Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS -
Thodsawit Tiyarattanachai
Masters Student in Biomedical Data Science, admitted Autumn 2023
Current Research and Scholarly Interestsartificial intelligence
medical imaging
ultrasound
screening and surveillance of liver cancer
cancer prediction models
cancer biomarkers -
Sara L. (Sally) Tobin
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsTobin is a Senior Research Scholar at the Stanford Center for Biomedical Ethics. She obtained her Ph.D. in Developmental Biology from the University of Washington and did postdoctoral research in Genetics at the University of California, Berkeley and in Biochemistry at the University of California, San Francisco. She became a faculty member at the University of Oklahoma College of Medicine in 1983 and moved to Stanford University in 1996. Her research contributions have been published in prestigious journals such as Cell, Nature, Genes & Development, Neuron, and Journal of Cell Biology.
Projects
With her collaborator, graphic designer Ann Boughton, Tobin has completed the production of three educational multimedia CD-ROM discs about the genetic revolution in medical care sparked by the rapid advances in our knowledge about the human genome. An on-line version derived and updated from these CDs is pending release through Twisted Ladder Media, and is entitled: "The New Genetics: Medicine and the Human Genome. Molecular Concepts, Applications, and Ramifications." In addition, Tobin and Boughton have collaborated on educational websites on inherited risk of breast cancer and on hereditary colorectal cancer with the Stanford Cancer Genetics Clinic.
Tobin's current major research interests include an educational project funded by the National Science Foundation to create and evaluate innovative modules for undergraduates entitled, "The New Genetics: Electronic Tools for Educational Innovation." The modules are presented in on-line form as an electronic course and are accompanied by workbook exercises and problem sets. The content includes principles of genetics, molecular genetic technologies, applications in medicine, environmental biology, agriculture, and society, as well as implications. In addition, she is collaborating on two projects that are exploring the ramifications of using genetic information about addiction risk in the judicial system.
Tobin is a member of the Benchside Consultation Team for the Center for the Integration of Research on Genetics and Ethics, and she evaluates clinical protocols for ethical issues for the Clinical Translational Research Program.
